Clinical Trial

Critical State of "Remission-Recurrence" of Ulcerative Colitis

Study acronym: CSRRUC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will recruit 100 patients with ulcerative colitis in remission for a 6-month non intervention follow-up observation. During the study, their conditions will be recorded truthfully, including general information, disease-related symptoms and signs, inflammatory bowel disease questionnaire, anxiety self-assessment scale, depression self-assessment scale, etc., every month. Collect blood, urine, and stool samples from patients every month for examination. Follow up for each subject until their condition recurs.
Trial Details
NCT Number NCT06694883
Lead Sponsor Beijing Hospital of Traditional Chinese Medicine
Conditions Ulcerative Colitis
Enrollment 100 participants
Start Date 2024-09-19
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2024-11-19